Effects of environmental risks and polygenic loading for schizophrenia on cortical thickness by Neilson, Emma et al.
This is an Open Access document downloaded from ORCA, Cardiff University's institutional
repository: http://orca.cf.ac.uk/100602/
This is the author’s version of a work that was submitted to / accepted for publication.
Citation for final published version:
Neilson, Emma, Bois, Catherine, Gibson, Jude, Duff, Barbara, Watson, Andrew, Roberts, Neil,
Brandon, Nicholas J., Dunlop, John, Hall, Jeremy, McIntosh, Andrew M., Whalley, Heather C. and
Lawrie, Stephen M. 2017. Effects of environmental risks and polygenic loading for schizophrenia
on cortical thickness. Schizophrenia Research 184 , pp. 128-136. 10.1016/j.schres.2016.12.011 file 
Publishers page: http://dx.doi.org/10.1016/j.schres.2016.12.011
<http://dx.doi.org/10.1016/j.schres.2016.12.011>
Please note: 
Changes made as a result of publishing processes such as copy-editing, formatting and page
numbers may not be reflected in this version. For the definitive version of this publication, please
refer to the published source. You are advised to consult the publisher’s version if you wish to cite
this paper.
This version is being made available in accordance with publisher policies. See 
http://orca.cf.ac.uk/policies.html for usage policies. Copyright and moral rights for publications
made available in ORCA are retained by the copyright holders.
Emma Neilson 
 
1 
 
Title: Effects of environmental risks and polygenic loading for schizophrenia on cortical 
thickness 
 
 
Emma Neilson 1a*, Catherine Bois 1b, Jude Gibson 1c, Barbara Duff 1d, Andrew Watson 1,2e, 
Neil Roberts 3f, Nicholas J. Brandon 4g, John Dunlop 4h, Jeremy Hall 5i, Andrew M. McIntosh 
1,2j
, Heather C. Whalley 1k and Stephen M. Lawrie 1,2l 
 
1 Division of Psychiatry, Centre for Brain Sciences, School of Clinical Sciences, University of 
Edinburgh, Royal Edinburgh Hospital, Morningside Park, Edinburgh, UK  
2Royal Edinburgh Hospital, Morningside Park, Edinburgh, UK  
3MRC Centre for Inflammation Research Centre for Brain Sciences, University of Edinburgh, The 
Queen’s Medical Research Institute, 47 Little France Crescent, Edinburgh, UK  
4AstraZeneca, IMED Neuroscience Unit, Waltham, MA, USA 
5Neuroscience and Mental Health Research Institute, Cardiff University School of Medicine, Cardiff, 
UK 
 
a: Emma Neilson, Address: Division of Psychiatry, 7th Floor Kennedy Tower, University of 
Edinburgh, Royal Edinburgh Hospital, Morningside Park, Edinburgh, EH10 5HF. Email: 
s0830415@sms.ed.ac.uk 
Mobile: 0131 537 6687  
 
b: C.bois@sms.ed.ac.uk 
c: jude.gibson@ed.ac.uk 
d: barbara.duff@ed.ac.uk 
e: awatson3@nhs.net 
f: neil.roberts@ed.ac.uk 
g: nick.brandon@azneuro.com 
h: john.dunlop@azneuro.com 
i: hallj10@cardiff.ac.uk 
j: andrew.mcintosh@ed.ac.uk 
k: heather.whalley@ed.ac.uk 
l: s.lawrie@ed.ac.uk 
 
 
 
 
 
Abstract 248 
Article Body 4,234 
Figures 3 
Tables 3 
Supplementary Material 
(Tables and Figures) 
24 
 
 
 
 
 
Emma Neilson 
 
2 
 
Abstract 
There are established differences in cortical thickness (CT) in schizophrenia (SCZ) and bipolar 
(BD) patients when compared to healthy controls (HC). However, it is unknown to what extent 
environmental or genetic risk factors impact on CT in these populations. We have investigated 
the effect of Environmental Risk Scores (ERS) and Polygenic Risk Scores for SCZ (PGRS-
SCZ) on CT.  
Structural MRI scans were acquired at 3T for patients with SCZ or BD (n=57) and controls 
(n=41). Cortical reconstructions were generated in FreeSurfer (v5.3). The ERS was created by 
determining exposure to cannabis use, childhood adverse events, migration, urbanicity and 
obstetric complications. The PGRS-SCZ were generated, for a subset of the sample 
(Patients=43, HC=32), based on the latest PGC GWAS findings. ANCOVAs were used to test 
the hypotheses that ERS and PGRS-SCZ relate to CT globally, and in frontal and temporal 
lobes. 
An increase in ERS was negatively associated with CT within temporal lobe for patients. A 
higher PGRS-SCZ was also related to global cortical thinning for patients. ERS effects 
remained significant when including PGRS-SCZ as a fixed effect. No relationship which 
survived FDR correction was found for ERS and PGRS-SCZ in controls. 
Environmental risk for SCZ was related to localised cortical thinning in patients with SCZ and 
BD, while increased PGRS-SCZ was associated with global cortical thinning. Genetic and 
environmental risk factors for SCZ appear therefore to have differential effects. This provides 
a mechanistic means by which different risk factors may contribute to the development of SCZ 
and BD.  
 
Keywords: Environmental risk, Polygenic risk, Schizophrenia, Bipolar Disorder, Structural 
MRI 
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1. Introduction  
Schizophrenia (SCZ) and bipolar disorder (BD) are psychiatric disorders characterised by 
overlapping symptomatology (Hilty et al., 2006; Bois et al., 2015) and multifactorial 
aetiologies (Hilty et al., 2006; Jablensky, 1997). Both are highly heritable (around 80%) due to 
a large number of relatively common genes of small effect (McGuffin et al., 2003; Matheson 
et al., 2011). Both have been proposed to be consistent with a neurodevelopmental model 
(Weinberger, 1987; Rapoport et al., 2012) which posits that SCZ and related disorders are 
influenced by both genetic and environmental factors impacting on the brain, at different 
developmental stages (Rapoport et al., 2012). Significant widespread cortical thinning is 
consistently found when comparing SCZ and BD patients to healthy controls (HC) (Kuperberg 
et al., 2003; Goldman et al., 2009; Rimol et al., 2010; Nesvåg et al., 2012; Knöchel et al., 2016). 
It is unclear however whether these differences are related to genetic and/or environmental risk 
factors previously associated with SCZ.  Elucidating these components would help to further 
understand the underlying aetiologies of these disorders. 
 
Decreases in grey matter volumes have been found before disease onset (McIntosh et al., 2011) 
and thinner cortices have been noted in SCZ patients when compared to HC in all lobes 
(Kuperberg et al., 2003; Goldman et al., 2009; Rimol et al., 2010). However, the most 
consistent findings have suggested that cortical thinning is most prominent in frontal and 
temporal regions (Kuperberg et al., 2003; Goldman et al., 2009; Rimol et al., 2010; van Haren 
et al., 2011; Sprooten et al., 2013), where it continues to decline after disease onset (Cobia et 
al., 2012). Despite reports of disease specific cortical thinning associated with BD, e.g. in 
orbitofrontal regions (Knöchel et al., 2016), many studies have also highlighted cortical 
thinning findings which overlap with the aforementioned SCZ deficits (Rimol 
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 et al., 2010; Hanford et al., 2016; Knöchel et al., 2016). Hence, frontal and temporal lobes are 
regions of interest for investigation of factors that could impact cortical deficits within SCZ 
and BD. 
 
Both SCZ and BD have been associated with several environmental risk factors (van Os et al., 
2010; Lawrie et al., 2011; Marangoni et al., 2016). Cannabis use, childhood adversity and 
obstetric complications (OC) have the strongest epidemiological evidence for an association 
with an increased risk of SCZ and BD, (Krabbendam & van Os, 2005; van Os et al., 2010; 
Rapoport et al., 2012; Matheson et al., 2013; Radhakrishnan et al., 2014; Stepniak et al., 2014; 
Marangoni et al., 2016). Urbanicity and migration are also strongly linked to SCZ 
(Krabbendam & van Os, 2005; van Os et al., 2010; Rapoport et al., 2012; Stepniak et al., 2014); 
however, as environmental risk factors for BD the evidence is less conclusive. Nevertheless, 
both migration and urbanicity have been linked to an increased incidence of BD (Pedersen & 
Mortensen, 2006; Cantor-Graae & Pedersen, 2013).  
 
Although the evidence is limited, some of these factors have also been linked to deficits in 
cortical volume and thickness. Cannabis use has been associated with reduced global and 
frontal lobe volumes (Welch et al., 2011), cortical thinning in general (Habets et al., 2011), 
and, more specifically, in dorso-lateral prefrontal cortex (DLPFC) and anterior cingulate cortex 
(Rais et al., 2010). Childhood adversity/trauma has been associated with global cortical 
thinning globally (Habets et al., 2011) and in the limbic system (Souza-Queiroz et al., 2016), 
as well as decreased subcortical structure volumes (Hoy et al., 2012; Barker et al., 2016a). So 
far, OC have not been significantly related to cortical thinning (Haukvik et al., 2009; Smith et 
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al., 2015) but birth complications have been previously linked to reduced hippocampal and 
cortical volume (Cannon et al., 2002; van Erp et al., 2002) and may, alone or in accumulation 
with other risk factors, be linked to deficits in cortical thickness (CT). Migration and urbanicity 
are yet to be investigated in relation to CT but urbanicity has been linked with decreased grey 
matter volume in DLPFC within a healthy sample (Haddad et al., 2015). 
 
Our knowledge of how these environmental risk factors impact upon CT in SCZ and BD is 
therefore inconclusive. Given a lack of knowledge about how these factors confer risk, it is 
desirable to determine if an accumulation of these risk factors has additional effects; some are 
likely to occur and impact development at different stages of life (Dean & Murray, 2005; 
Stepniak et al., 2014) and several of these factors can be experienced by any individual. Prima 
facie, it seems likely that a higher number of insults may result in greater biological effects. 
One aim of the current study is therefore to determine the impact of environmental risk factors, 
in accumulation, on CT. 
 
Genome Wide Association Studies (GWAS) have advanced our understanding of the genetic 
underpinnings of SCZ and BD. Recently, the Schizophrenia Working Group of the Psychiatric 
Genomics Consortium (SWG-PGC) GWAS (2014) identified 108 genetic loci associated with 
SCZ, as well as several other markers that failed to reach genome-wide significance, suggesting 
a polygenic foundation to SCZ, with many genetic variants of individually small effect 
contributing to the overall phenotypic variation (International Schizophrenia Consortium., 
2009). Strong evidence also exists for a polygenic basis for BD, with a strong overlap in the 
genetic variants associated with SCZ and BD (International Schizophrenia Consortium, 2009; 
Cross-Disorder Group of the Psychiatric Genomics Consortium, 2013; Ripke et al., 2013). 
Using the summary data from the SWG-PGC GWAS (including alleles associated with the risk 
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of SCZ as well as their effect sizes) as the training dataset, PGRS-SCZ can be created in an 
independent sample. Risk variants in the independent sample which are common to the training 
dataset are identified, these are then weighted by the effect sizes reported in the SWG-PGC 
GWAS and summed across individual genotypes in the independent sample (International 
Schizophrenia Consortium., 2009; Schizophrenia Working Group of the Psychiatric Genomics 
Consortium, 2014; Euesden et al., 2015). Higher positive scores indicate a greater polygenic 
risk for SCZ disorder. 
 
Several studies have investigated the effect of these PGRS for SCZ (PGRS-SCZ) on clinical 
and cognitive phenotypes (McIntosh et al., 2013; Stepniak et al., 2014; Whalley et al., 2016).  
Thus far, structural neuroimaging phenotypes have been assessed with regard to the first SWG-
PGC GWAS data, which identified 7 associated loci (Schizophrenia Psychiatric Genome-Wide 
Association Study Consortium, 2011), with inconsistent results (Terwisscha van Scheltinga et 
al., 2013; Papiol et al., 2014), making further investigation warranted.  
 
Despite the fact that risk variants have been identified for BD separately (Psychiatric GWAS 
Consortium Bipolar Disorder Working Group, 2011), there is still a substantial amount of 
shared variation between these psychiatric disorders (Cross-Disorder Group of the Psychiatric 
Genomics Conosrtium, 2013; Ripke et al., 2013). Furthermore, PGRS-SCZ have been 
previously used for analysis within a combined BD and SCZ patient group (Ruderfer et al., 
2014). Therefore, as the intention of the current study is to determine whether risks common 
to the development of both BD and SCZ are linked to CT, and the SCZ GWAS is more highly 
powered than the BD GWAS (Psychiatric GWAS Consortium Bipolar Disorder Working 
Group, 2011; Schizophrenia Working Group of the Psychiatric Genomics Consortium, 2014), 
Emma Neilson 
 
7 
 
we have used the PGRS-SCZ. A second aim of the current study is to determine if a relationship 
exists between PGRS-SCZ, created using the most recent PGC SCZ data, and CT.  
 
Within the current study, global, frontal and temporal regions of CT were analysed to determine 
their relationship with PGRS-SCZ and environmental risk associated with SCZ. We 
hypothesised that both PGRS-SCZ and an accumulation of environmental risk factors would 
be inversely associated with cortical thinning in these regions, for both the patients and controls 
separately and when assessing differences between patients and controls. Due to the 
aforementioned overlap between structural findings, environmental, and genetic risk factors, 
and in order to increase power within the sample, SCZ and BD patient data were combined 
into one patient groups for analyses. 
 
2. Methods  
2.1 Participants  
Detailed participant information has been reported previously (Whalley et al., 2015). Briefly, 
participants were recruited as part of the Scottish Family Mental Health Study, approved by 
the Multicentre Research Ethics Committee for Scotland (09/MRE00/81). Detailed clinical and 
MRI data were obtained for HC (n=41) and patients with a DSM-IV diagnosis of SCZ (n=38) 
or BD (n=20) aged between 18 and 67 years. Clinical diagnoses were established using the 
structural interview for the DSM-IV (SCID; (First et al., 2002) conducted by one of two trained 
psychiatrists. For analyses purposes, SCZ and BD participants were combined into one patient 
group. Table 1 shows demographic information for both groups.   
 
----------------------------------- 
Insert Table 1 Here 
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----------------------------------- 
 
 
2.2 Imaging Procedures 
MR imaging was performed at Edinburgh’s Clinical Research Imaging Centre (CRIC) 
(http://www.cric.ed.ac.uk/) on a Siemens Verio 3T MRI system (Siemens Medical Systems, 
Erlangen). Structural brain images were acquired using a T1-weighted magnetization prepared 
rapid acquisition gradient sequence parallel to the AC-PC line (repetition time 2300ms, echo 
time 2.98ms, inversion time 900ms, flip angle 9°) resulting in 160 contiguous 1mm slices of 
256x256 voxels. 
 
Brain scans were anonymised at the time of acquisition and a set protocol was adhered to for 
pre-processing of scans, regardless of clinical status. Structural images were processed using 
FreeSurfer (v5.3) (http://surfer.nmr.mgh.harvard.edu/fswiki/) to quantify thickness of cortical 
anatomical regions, volumetric segmentation, cortical surface reconstructions and cortical 
parcellation. See Supplement 1 for full procedure. The Desikan-Killiany atlas was used to 
define cortical anatomical regions (Desikan et al., 2006). A list of the regions of interest 
included in frontal and temporal lobes, using this atlas, can be found in Supplement 1. 
 
A trained rater (E.N.) checked all scans for inaccuracies, blinded to group status. All scans 
were edited adhering to FreeSurfer procedures (http://freesurfer.net/fswiki/Edits) in order to 
increase the accuracy of the pial surface. Following this procedure, one scan was removed due 
to defective surface generation that could not be corrected by manual editing (HC=41, 
Patient=57). Average global and lobar CT values were extracted from each scan for analysis. 
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2.3 Environmental Measures  
Environmental risk information was collected for all 98 participants. The risk factor measures 
and subsequent calculation of an Environmental Risk Score (ERS) were based upon methods 
developed by Stepniak et al. (2014) and included three factors for controls; Childhood Adverse 
Events (CAE), Migration, and Cannabis Use, with a further two for the patient group; OC and 
Urbanicity. Environmental measures were defined as follows: CAE – measured using the 
Childhood Life Events Questionnaire (CLEQ, www.bdrn.org) which determined if participants 
had experienced one or more event out of a possible list of 13 adverse childhood events 
including death of a parent/friend, parental divorce and personal/parental hospitalisation. 
Abuse and bullying are not specifically enquired about, however a final question allows 
participants to disclose any other CAE not previously specified. Risk was recorded if the 
participant experienced one or more of the possible events as opposed to none; Migration – 
whether the participant migrated to the United Kingdom from another country; Cannabis Use 
– any recorded cannabis use before the time of scan;  OCs – any deviation from normal 
pregnancy or delivery (e.g. premature birth, jaundice); Urbanicity – calculated using the 
measure from Stepniak et al. (2014), to determine the cities that patients lived in from birth to 
18 years old. Each city was placed into a category depending on its population (1: </= 10,000, 
2: 10,001-50,000, 3: 50,001-100,000, 4: > 100,000) and was multiplied depending on the 
number of years spent living in that place. This was repeated for each city if the participant 
relocated and all scores were summed. The total score was then split into one of 2 groups - 
rural (score 18-45) and urban (score 46-72) upbringing, with placement in the urban group 
conferring risk. Environmental measures were scored as 1 or 0; with 1 representing that the 
risk was present for each participant. Frequencies of the individual factors for the combined 
patient groups and controls are displayed in Supplement 2, Tables S1-2. Participants with 
unavailable information (NA) on factors were rated, conservatively, as 0, however, analyses 
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with NA removed were also conducted with results reported in Supplement 2. The continuous 
ERS was determined by totalling the number of environmental measures experienced by each 
participant.  
 
2.4 Genotyping and derivation of PGRS 
Information on the genotyping process are presented in Supplement 1.  
Polygenic profile scores were generated using imputed genotype data. Imputation was 
performed in accordance with the ENIGMA 1000 genomes protocol (ENIGMA2 Genetics 
Support Team, 2013) Single nucleotide polymorphisms (SNPs) with an imputation R-squared 
quality score of >0.3 were retained for further analysis resulting in 6,145,246 SNPs. All 
subsequent analyses were performed in PLINK (Purcell et al., 2007). Further QC criteria were 
applied to imputed data. Individuals with missingness >2% were excluded, as were SNPs with 
a genotype call rate of <98%, Hardy-Weinberg equilibrium p-value <1 x 10-6, a minor allele 
frequency of <5%, or those that were strand ambiguous. Clump-based linkage disequilibrium 
pruning (r2 0.2, 300kb window) was performed to create a SNP-set in approximate linkage 
equilibrium. Marker weights (logarithm of the Odds Ratio) and p-value association statistics 
for SNPs were derived from the most recent PGC GWAS of schizophrenia (9.8 million 
autosomal SNPs) (Schizophrenia Working Group of the Psychiatric Genomics Consortium, 
2014). Five scores were generated for each individual, using SNPs selected according to the 
significance of their association with the phenotype in the discovery GWAS at nominal P-value 
thresholds of 0.01, 0.05, 0.1, 05, 1, as previously described (International Schizophrenia 
Consortium, 2009). These data were not available for 11 of the patients and 8 of the controls 
and they were therefore excluded (Patients=46, HC=33).  
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Multi-dimensional scaling (MDS) was conducted to identify outliers within the population 
stratification using previously described protocols (ENIGMA2 Genetics Support Team, 2013). 
In plotting the MDS components, three outliers were identified and removed (Supplement 1, 
Figure S1). Four MDS components were included in subsequent PGRS-SCZ analysis models 
within this study, consistent with previous publications (McIntosh et al., 2013; Whalley et al., 
2015). Where sibling pairs were present in the sample, one half was removed to avoid 
relatedness issues, making the final sample with genotyped information HC=32, Patients=43.  
 
2.5 Statistical analysis  
Statistical analyses were conducted in R (v3.2.2). The effects of left and right global, frontal 
and temporal CT were investigated in line with our hypotheses. SCZ and BD patient data were 
combined into one patient group due to overlap between genetic risk, environmental risk and 
structural MRI findings. However, a secondary analysis examining the patients separately was 
performed and reported in Supplement 3.  
 
Firstly, we assessed whether an accumulative ERS and, post-hoc, individual environmental 
risks were related to CT. Secondly, we tested for associations between CT and PGRS-SCZ and 
finally, we calculated whether any environmental effects remained after controlling for 
potential genetic effects. As the aim of the study was to determine whether there was an effect 
of environmental and polygenic risk on CT, and more environmental information was available 
for patients than controls, analyses were conducted separately for each of these groups. 
However, we also tested for potential differential effects when comparing patients and controls 
using the three environmental factors common to both groups, as well as the PGRS-SCZ. 
ANCOVAs were run for each anatomical structure with the structure of interest entered as the 
outcome variable and ERS/PGRS-SCZ as the predictor variable. Results for all lobar structure 
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analyses for ERS and PGRS analyses were corrected for multiple comparisons using a False 
Discovery Rate (FDR) correction, with a rate of p=0.05 (Genovese et al., 2002). Post-hoc 
analyses were run to test for the effects of individual environmental risk factors on CT. Due to 
these factors all being correlated with the ERS (Supplement 1, Table S1-2), post-hoc analyses 
were FDR corrected across lobes and all individual environmental risk factors. 
 
For the ERS analyses, using the combined patient group and controls separately, covariates 
included age (mean centred) and gender, with group (SCZ/BD) added as a fixed effect within 
patient models to control for potential group differences. ERS was the predictor of interest 
within the main environmental analysis. For additional post-hoc analyses the individual risk 
factor was the predictor variable. Age (mean centred), gender, and group for the patient 
analyses, were also included as fixed effects in the PGRS analyses as well as four MDS 
components and the standardised PGRS at threshold p≤0.1. This threshold was utilised as it 
was shown to explain the most phenotypic variance in the discovery cohort (Schizophrenia 
Working Group of the Psychiatric Genomics Consortium, 2014). Results at the 4 other 
thresholds (p≤0.01, 0.05, 0.5 and 1) are presented in Supplement 2. Total average thickness 
was added as a covariate for all frontal and temporal lobar analyses. The same models with the 
inclusion of an ERS or individual environmental risk factor/PGRS-SCZ by group interaction 
factor was also run to investigate potential group differences between the combined patient 
group and controls. 
 
A further analysis model, including the above ERS covariates, the PGRS-SCZ variables 
included as fixed effects and ERS as the predictor variable, was tested to determine the effect 
of ERS whilst controlling for PGRS-SCZ. 
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Power was also calculated for the environmental risk analyses. As there is no previous effect 
size in the literature that links an accumulative ERS to CT, we estimated this based on a review 
by Lawrie et al. (2011), which includes the OR of many of the risk factors within the current 
study. Based on this review, we took an overall summary OR of 2 which is conservative as the 
OR for immigration for example is 5 (Lawrie et al., 2011). We converted this OR to an effect 
size using methods described in Chinn et al. (2000). Using this effect size in conjunction with 
sample size information for the current sample, we calculated power for the current study using 
the ‘pwr’ package in R. The results suggest that we have 88-96% power to detect relationships 
at p=0.05 within the current sample. 
 
Chlorpromazine equivalents (CPZE) of patient’s antipsychotic use were calculated using 
previous methods (Woods, 2003). Spearman’s rank correlations revealed no significant 
relationship between CPZE and the current brain parameters.  
 
3. Results 
3.1 Group Differences 
No significant differences were found for age, gender or premorbid IQ between the combined 
patient group and controls, but significant differences were found for SES, YMRS, HDRS and 
symptom severity (Table 1). 
 
There was a significant difference in CT between patients and controls in global left and right, 
and right temporal lobes (Table 2), due to patients having significantly thinner cortices in these 
regions compared to controls. 
 
----------------------------------- 
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Insert Table 2 Here 
----------------------------------- 
 
A significant difference in PGRS-SCZ was also evident between groups (Table 1); patients had 
a higher mean score than controls at the p≤0.1 threshold (t69.17=-2.62, p=0.01). Supplement 2, 
Table S3 presents differences at other thresholds.  
 
There was also a significant group difference in ERS (Table 1); patients experienced a higher 
mean number of environmental risks compared to controls (t78.75= -2.3, p=0.02). 
 
Analyses were also conducted to determine potential group differences between SCZ and BD 
patients and are reported in Supplement 3, Table S1-2. No significant differences were found 
between these groups, with the exception of PANSS Positive Symptoms. 
 
3.2 Patient Analyses 
3.2.1 ERS Analyses  
A significant main effect was found for ERS (F1,51=7.23, p=0.01) which survived FDR 
correction (pcorrected=0.04); an increase in ERS was associated with a thinner right temporal 
cortex (Table 3).  
 
----------------------------------- 
Insert Table 3 Here 
----------------------------------- 
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3.2.1.1 Post-hoc Analyses of Individual Environmental Risk Factors 
Post-hoc analyses of individual environmental risk factors revealed no significant main effects 
which survived FDR correction (Supplement 2, Table S4). 
No effects of group were found for the ERS or individual environmental risk analyses.  
 
3.2.2 PGRS-SCZ Analyses  
A significant main effect of PGRS-SCZ on Global CT was found in left (F1,33=4.33, p=0.05) 
and right (F1,33=4.54, p=0.04) hemispheres, due to a negative relationship between PGRS-SCZ 
and CT (Figures 1a and b). No main effect of group was found in these regions. No significant 
effects were found for any other structures (Supplement 2, Table S12). 
 
 
 
----------------------------------- 
Insert Figures 1a and b Here 
----------------------------------- 
 
3.2.3 ERS controlling for PGRS-SCZ Analyses  
When adjusting for possible effects of PGRS-SCZ, the main effects of ERS on CT in right 
temporal lobe remained significant (F1,31=5.74, p=0.02).  
 
3.3 HC Analyses 
3.3.1 ERS Analyses  
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A main effect of ERS was apparent in controls within left and right temporal lobes but did not 
survive FDR correction. The pattern of this effect suggested that a higher ERS was associated 
with thicker temporal cortices. 
 
3.3.1.1 Post-hoc Analyses of Individual Environmental Risk Factors 
Post-hoc analyses of individual factors suggested a main effect of CAE on left and right 
temporal lobes which did not survive FDR correction but displayed the pattern that those who 
had experienced CAE had greater CT within these regions, compared to those who had not. No 
other factor had a significant effect (Supplement 2, Table S6). 
            
3.3.2 PGRS Analyses  
PGRS-SCZ did not have an effect on any of the structural parameters in controls. (Supplement 
2, S13) 
 
3.4 Interaction Analyses 
3.4.1 Group*Environmental Risk Analyses 
There was a significant ERS by group interaction in right temporal lobes (F1,91=6.23, p=0.01); 
a higher risk score was associated with a thicker right temporal cortex within controls, but a 
thinner cortex within patients. However, after FDR correction, this result only revealed a trend 
towards significance (pcorrected=0.06). There were no other associations for any other structures 
and there were no significant main effects for ERS (Supplement 2, Table S8 and S10). 
 
3.4.1.1 Post-hoc Analyses of Individual Environmental Risk Factors 
Post-hoc analyses revealed significant CAE by group interactions in right temporal lobe, 
surviving FDR correction (F1,91=6.27, p=0.01, pcorrected=0.04). This was due to thicker cortices 
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for those controls who had experienced CAE compared to those who had not; whereas, in the 
patient group, the opposite pattern was apparent. No other individual risk factors were 
significant (Supplement 2, Table S8 and S10). 
 
3.4.2 Group*PGRS-SCZ Analyses 
There was a significant main effect of PGRS-SCZ in left (F1,64=8.41, p=0.01) and right 
(F1,64=10.22, p<0.01) hemispheres; an increase in PGRS-SCZ was associated with a thinner 
cortex within these regions, regardless of group (Figures 2a and b). There were no other 
significant main effects (Supplement 2, Table S14). 
 
----------------------------------- 
Insert Figures 2a and b Here 
----------------------------------- 
 
 
There was also a significant group by PGRS-SCZ interaction in left temporal lobe which 
withstood FDR correction (F1,63=6.88, p=0.01, pcorrected=0.04). This was due to an increase in 
PGRS-SCZ being associated with a thinner cortex within patients (Figure 3a) but having no 
relationship in controls (Figure 3b). No other interactions reached significance (Supplement 2, 
Table S15). 
 
----------------------------------- 
Insert Figures 3a and b Here 
----------------------------------- 
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3.4.3 Group*ERS controlling for PGRS Analyses 
When controlling for potential effects of PGRS on ERS, the significant ERS by group 
interaction remained for right temporal lobe (F1,62=4.51, p=0.04). The CAE group interaction, 
also remained significant (F1,62=7.22, p=0.01). 
4. Discussion  
We examined whether an ERS, as well as PGRS-SCZ were associated with CT within a patient 
group (SCZ/BD) and HC. We report that an ERS for SCZ negatively affected right temporal 
CT within patients. Importantly, these effects were robust to controlling for PGRS-SCZ, and 
to FDR correction.  Environmental risk factors were associated with a thicker cortex within 
controls, but did not survive FDR correction. Interaction analyses revealed a significant group 
by ERS interaction in right temporal lobe, in that, a thinner cortex was associated with 
increased ERS within patients whereas the opposite pattern was apparent within controls; albeit 
this interaction was a trend after FDR correction. There was also a significant group by PGRS-
SCZ interaction in left temporal lobe, with higher PGRS-SCZ being related to a thinner cortex 
within patients whereas no relationship was apparent for controls. 
 
Cortical thinning in temporal lobe is commonly found in patients with SCZ and BD (Kuperberg 
et al., 2003; Goldman et al., 2009; Rimol et al., 2010; van Haren et al., 2011; Hanford et al., 
2016). As far as we are aware, our results provide the first evidence that an accumulation of 
environmental risk factors contribute to cortical thinning within this area. The opposite effect 
was seen in the separate analyses of control individuals, and in the interaction between the two 
groups, but these results did not survive FDR correction, possibly due to comparatively low 
power for these analyses.  
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We also found an interaction within right temporal lobe due to a thicker cortex in HC in 
association with experiencing CAE, whereas patients who experienced the same insult had 
thinner temporal cortices. Although CAE have been formerly linked to thinner cortices in 
patients (Habets et al., 2011), they have not been previously associated with a thicker cortex in 
controls. Habets et al. (2011) found a thicker cortex to be associated with increased levels of 
developmental trauma in siblings of SCZ patients, but not in controls. We, however, did not 
previously find this effect in those at familial high-risk (Barker et al., 2016b).  Our current 
replication of Habets et al. (2011) does support the possibility that experiencing CAE could 
thicken the cortex and may be related to resilience to developing a psychotic disorder. Within 
healthy populations, studies have shown that increased participation in practices which may 
promote mental wellbeing, such as meditation (Lazar et al., 2005; Kang et al., 2013) and 
physical exercise (Reiter et al., 2015), is associated with having a thicker temporal cortex, 
amongst other areas.  
 
An important point to acknowledge is that we received less full histories for ERS derivation in 
controls than patients; however, the present study has also directly compared the environmental 
risk factors common to both patients and controls. We report a group by ERS interaction in 
right temporal CT, whereby higher ERS was associated with a thinner cortex within patients 
but a thicker cortex in controls. We also report a group by CAE interaction in right temporal 
lobe. These results suggest a differential effect of environmental risk in patients and controls 
but must be interpreted with caution and require replication in much larger cohorts.  
 
We also report significant negative relationships between PGRS-SCZ and global CT within 
both the patient only analysis, and the full sample, irrespective of group. To our knowledge, 
this has not been previously reported – although we and others have reported thinner cortices 
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in those at familial high-risk of SCZ (Goghari et al., 2007; Byun et al., 2012; Sprooten et al., 
2013). Previously, increased PGRS-SCZ have been linked to a reduction in white matter 
volume (Terwisscha van Scheltinga et al., 2013) and decreased gyrification in general 
populations (Liu et al., 2016) however this is the first evidence linking genetic loading for SCZ 
to CT. Based on our findings we hypothesise that genetic risk for SCZ could disrupt global CT 
during development and thereby increase the risk of developing SCZ.  
 
A significant group by PGRS-SCZ interaction was reported; a thinner cortex in left temporal 
lobe was associated with higher PGRS-SCZ in the patient group, but had no association with 
PGRS-SCZ in controls. This suggests potential localised differential effects between patients 
and controls.  
 
In the current study, we used PGRS for SCZ rather than BD for several reasons. Firstly, we 
were interested in determining the commonalities between these disorders and how they may 
impact upon CT. Secondly, PGRS-SCZ have been used previously within BD populations 
(Ruderfer et al., 2014). Thirdly, the original GWAS for SCZ was better powered that that for 
BD (Psychiatric GWAS Consortium Bipolar Disorder Working Group, 2011; Schizophrenia 
Working Group of the Psychiatric Genomics Consortium, 2014). However, it would be of 
interest for future studies to determine the effects of the PGRS-BD in a larger sample. 
  
Given the potential interactive effects of genetic and environmental risk factors for SCZ on 
neuroanatomy, we conducted further analyses to determine whether the effects of 
environmental factors persisted after controlling for PGRS-SCZ. We report that all 
environmental effects remained significant after so doing. We cannot rule out a gene-
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environment interaction of PGRS-SCZ and ERS on CT, but our results do suggest that the 
effects of genetic and environmental risks for SCZ are not the same.  
 
A further limitation within this study is that we were not able to conduct corroborative 
interviews with e.g. parents therefore, it is likely that there is some missing information for 
individual environmental risk factors. We therefore decided that missing information (NAs) 
should be recorded as a 0 when calculating the ERS. This was considered the best approach, in 
order to include as much information as possible without potentially overstating the effect of 
environmental factors on brain structure. Additional analyses were also conducted with all NAs 
removed and are reported in Supplement 2. The results of these analyses showed a similar 
pattern to those reported here but did not survive FDR correction. However, by removing the 
NAs a substantial amount of data was lost suggesting that the lack of significance may reflect 
low power rather than the lack of an effect. This outcome provides further support for the 
current approach, but analyses within a larger cohort is necessary to determine if the effects 
can be replicated. 
 
Together, our results suggest that experiencing environmental risks for SCZ contributes to 
localised cortical thinning in patients with SCZ and BD. Higher genetic loading is associated 
with global cortical thinning but does not account for the effects of environmental risk. We 
thus provide further evidence for a neurodevelopmental model for SCZ which posits that both 
environmental and genetic factors contribute to the development of the disorders. Further, our 
results suggest that it might be possible to develop intervention strategies to address 
environmental risks for SCZ and measure their effect on CT. 
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Figure Legends 
Figure 1. Global a) left and b) right cortical thickness, in mm2, and polygenic risk scores for 
schizophrenia in the combined patient group (SZ=37, BD=20). 
 
Figure 2. Graphs showing that global a) left and b) right cortical thickness, in mm2, is 
negatively associated with increased polygenic risk scores for schizophrenia, regardless of 
group (HC=32, Patient=43). 
 
Figure 3. Graphs showing left temporal lobe cortical thickness, is a) negatively associated with 
polygenic risk scores in the combined patient group (n=43) and b) has no relationship with 
polygenic risk scores for schizophrenia in the HC group (n=32). 
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Tables  
Table 1. Demographic information in healthy controls and combined patient group 
 HC Patient 
M(SD) 
t/X2 p 
N 41 57   
Age 38.22 39.21 0.47 0.64 
Gender 
(Male/Female) 
23/18 37/20 0.45 0.50 
Illness Duration - 17.95 
(11.81) 
Range: 0-45 
 
- - 
Age of Onset - 21.96 (9.17) 
Range: 7-53 
- - 
CPZ equivalent 
(ENIGMA) 
- 252.55 - - 
PANSS Total 31.54 54.38 -9.02 6.136e-13 
PANNS Positive 7.17 12.45 -7.44 5.572e-10 
PANSS Negative 7.29 13.38 -6.40 2.48e-08 
PANSS General 17.07 28.55 -8.59 8.217e-13 
SES   29.71 1.683e-05 
Unemployed/Retired 1/5 26/8  
Manual/non-manual 8/28 7/15  
Young Mania 
Rating Scale 
0.14 2.75 -4.96 6.385e-06 
Hamilton 
Depression Rating 
Scale 
0.87 9.98 -7.50 1.434e-10 
Paternal Age - 31.05 (6.68) - - 
NART IQ 111.2 110.5 0.44 0.66 
PGRS -0.33 0.25 -2.62 0.01 
ERS 1.292 1.684 -2.311 0.02 
 
 
 
Table 2. Mean group differences in cortical thickness with standard deviations and p values 
 
 
Controls (n=41) 
 
Patients (n=57) 
 
  
 Mean (SD) Mean (SD) F P 
Left 2.52 (0.10) 2.44 (0.11)  11.63 0.001 
Right 2.51 (0.09) 2.43 (0.10) 14.78 0.0002 
Frontal Left 2.56 (0.11) 2.49 (0.13) 0.83 0.36 
Frontal Right 2.49 (0.11) 2.44 (0.13) 3.64 0.06 
Temporal Left 2.86 (0.12) 2.74 (0.17) 1.61 0.21 
Temporal Right 2.91 (0.12) 2.77 (0.15) 5.60 0.02 
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Table 3. Adjusted Mean Thickness, along with standard errors (SE), in Right Temporal Lobe 
dependent on the number of environmental risk factors experienced by the patients (n=57) 
 0 Risks 1 Risk 2 Risks 3 Risks 4 Risks 5 Risks 
Adjusted Mean 
Thickness (mm2) 
2.85 2.82 2.79 2.76 2.73 2.70 
SE 0.03 0.02 0.01 0.01 0.02 0.03 
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